stf-62247 (Millipore)
Structured Review
Stf 62247, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stf-62247/stf+62247/pm35792180-177-31-34
Average 90 stars, based on 1 article reviews
Images
Related Articles
Incubation:Article Title: Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism. Article Snippet: Doxorubicin (DOX) is classified by World Health Organization (WHO) as an essential medicine for cancer.. However, its clinical application is limited due to resistance development and cardiotoxicity.. Many attempts have been made to address these issues with some focused on finding a potential adjuvant therapy. Article Title: Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines Article Snippet: STF-62247, an Positive Control:Article Title: Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism. Article Snippet: Doxorubicin (DOX) is classified by World Health Organization (WHO) as an essential medicine for cancer.. However, its clinical application is limited due to resistance development and cardiotoxicity.. Many attempts have been made to address these issues with some focused on finding a potential adjuvant therapy. Article Title: Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines Article Snippet: STF-62247, an Concentration Assay:Article Title: Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism. Article Snippet: Doxorubicin (DOX) is classified by World Health Organization (WHO) as an essential medicine for cancer.. However, its clinical application is limited due to resistance development and cardiotoxicity.. Many attempts have been made to address these issues with some focused on finding a potential adjuvant therapy. Article Title: Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines Article Snippet: STF-62247, an |
